St Jude raises bet on heart failure market with $3.4bn Thoratec buy
This article was originally published in Clinica
Executive Summary
St Jude Medical plans to be the first of the big cardiovascular device companies to sell ventricular assist devices after agreeing to buy leading VAD-maker Thoratec. But there is a possibility that another rival might swoop in to scupper the deal.